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Background: Several earlier studies report that durable midterm outcomes of endovascular treatment (EVT) with nitinol stents for the 
femoropopliteal (FP) segment. However, treatment for in-stent restenosis (ISR) has not been clinically examined. Therefore, we investigated outcomes 
of plain balloon angioplasty for ISR in the FP segment, and risk-stratified recurrent ISR.
methods: From January 2004 and December 2011, 114 ISR FP lesions in 98 patients (mean age 70±10 years, 68.5% men) were treated by plain 
balloon angioplasty. The lesions were classified by angiographic pattern: class I, focal restenosis (≤ 50mm in length); class II, diffuse lesions (≥ 
50mm lengths); and class III, totally occluded ISR. Study outcomes included rate and predictors of recurrent ISR. Cox proportional hazards models 
were used to assess independent predictors for recurrent ISR.
results: Thirty-six patients (37%) had critical limb ischemia, 66 patients (68%) had diabetes mellitus and 34 patients (35%) were on 
hemodialysis. Average treated length and reference diameter was 168±90mm and 5.5±0.6mm, respectively. There were 24 (21%) class I, 56 (49%) 
class II, and 33 (29%) class III lesions. At 12 and 36 months, recurrent ISR rate for Class I, II, and III lesions was 10%, 12%, and 34%, and 39%, 48%, 
and 81%, respectively. By Cox multivariate regression analysis, diabetes mellitus, ISR class III and BTK run-off ≤ 1 were the predictors for recurrent 
ISR. After stratification of freedom from recurrent ISR according to the number of risk factors, it was lower in the higher risk groups (1-year rates by 
number of risk factors: 0, 100%; 1-2, 80.0%; 3, 37.5%, respectively).
conclusions: The mid-term outcomes of balloon angioplasty for stenotic ISR in the FP segment were acceptable. Risk stratification based on 
predictors allows estimation for future occurrence of recurrent ISR.
